These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31597277)

  • 21. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
    Thabet Y; Klingmann V; Breitkreutz J
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.
    Sosnik A; Seremeta KP; Imperiale JC; Chiappetta DA
    Expert Opin Drug Deliv; 2012 Mar; 9(3):303-23. PubMed ID: 22257003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019.
    delMoral-Sanchez JM; Gonzalez-Alvarez I; Gonzalez-Alvarez M; Navarro-Ruiz A; Bermejo M
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32244848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future.
    Schultz MJ; Dunser MW; Dondorp AM; Adhikari NK; Iyer S; Kwizera A; Lubell Y; Papali A; Pisani L; Riviello BD; Angus DC; Azevedo LC; Baker T; Diaz JV; Festic E; Haniffa R; Jawa R; Jacob ST; Kissoon N; Lodha R; Martin-Loeches I; Lundeg G; Misango D; Mer M; Mohanty S; Murthy S; Musa N; Nakibuuka J; Serpa Neto A; Nguyen Thi Hoang M; Nguyen Thien B; Pattnaik R; Phua J; Preller J; Povoa P; Ranjit S; Talmor D; Thevanayagam J; Thwaites CL;
    Intensive Care Med; 2017 May; 43(5):612-624. PubMed ID: 28349179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation Challenges and Strategies to Develop Pediatric Dosage Forms.
    Malkawi WA; AlRafayah E; AlHazabreh M; AbuLaila S; Al-Ghananeem AM
    Children (Basel); 2022 Apr; 9(4):. PubMed ID: 35455532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Better medicines for children' within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda.
    Nsabagasani X; Ogwal-Okeng J; Hansen EH; Mbonye A; Muyinda H; Ssengooba F
    J Pharm Policy Pract; 2016; 9():22. PubMed ID: 27280024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing and developing suppository formulations for anti-HIV drug delivery.
    Ham AS; Buckheit RW
    Ther Deliv; 2017 Aug; 8(9):805-817. PubMed ID: 28825395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Access to medicines through health systems in low- and middle-income countries.
    Ozawa S; Shankar R; Leopold C; Orubu S
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii1-iii3. PubMed ID: 31816069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study.
    Venables R; Batchelor H; Stirling H; Marriott J
    Int J Pharm; 2016 Jan; 497(1-2):12-7. PubMed ID: 26611666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Piroxicam: new dosage forms.
    Norris E; Guttadauria M
    Eur J Rheumatol Inflamm; 1987; 8(1):94-104. PubMed ID: 3305038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007.
    Strickley RG
    J Pharm Sci; 2019 Apr; 108(4):1335-1365. PubMed ID: 30447227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Financing pediatric surgery in low-, and middle-income countries.
    Hsiung G; Abdullah F
    Semin Pediatr Surg; 2016 Feb; 25(1):10-4. PubMed ID: 26831132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Brion F; Nunn AJ; Rieutord A
    Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.
    Lopez FL; Ernest TB; Tuleu C; Gul MO
    Expert Opin Drug Deliv; 2015; 12(11):1727-40. PubMed ID: 26165848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Problems with oral formulations prescribed to children: a focus group study of healthcare professionals.
    Venables R; Stirling H; Batchelor H; Marriott J
    Int J Clin Pharm; 2015 Dec; 37(6):1057-67. PubMed ID: 26173937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reflection on the Pharmaceutical Formulation Challenges Associated with a Paediatric Investigation Plan for an Off-Patent Drug.
    Walsh J
    AAPS PharmSciTech; 2017 Feb; 18(2):250-256. PubMed ID: 27097815
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.